Mizuho Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Mizuho Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$188K	Sell	2,150 -1,108	-34%	-$105K	0.04%	302
2016 Q2	$280K	Buy	3,258 +1,628	+100%	+$141K	0.05%	286
2016 Q1	$192K	Sell	1,630 -1,415	-46%	-$128K	0.05%	235
2015 Q4	$383K	Buy	3,045 +485	+19%	+$58.5K	0.08%	210
2015 Q3	$267K	Buy	2,560 +441	+21%	+$56.7K	0.06%	234
2015 Q2	$262K	Buy	2,119 +489	+30%	+$61.6K	0.06%	226
2015 Q1	$192K	Buy	1,630 +513	+46%	+$61.5K	0.05%	235
2014 Q4	$133K	Buy	1,117 +317	+40%	+$35.7K	0.04%	230
2014 Q3	$90K	Buy	800 +212	+36%	+$20.2K	0.02%	257
2014 Q2	$56K	Hold	588	–	–	0.01%	302
2014 Q1	$42K	Hold	588	–	–	0.01%	311
2013 Q4	$44K	Hold	588	–	–	0.01%	295
2013 Q3	$45K	Hold	588	–	–	0.01%	294
2013 Q2	$47K	Buy	+588	New	+$43.3K	0.01%	274

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Mizuho Asset Management's VRTX Position: Q3 2016 in Review

Mizuho Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 34% in Q3 2016, selling an estimated $105K and leaving 2,150 shares worth $188K. The position accounts for 0.04% of the portfolio, ranked #302.

Mizuho Asset Management first reported a position in VRTX in Q2 2013 and has held it in 14 quarters since. The position peaked at $383K in Q4 2015. 490 funds tracked by Wall St. Rank hold VRTX as of Q3 2016.

Mizuho Asset Management held 2,150 shares of Vertex Pharmaceuticals worth $188K as of Q3 2016.
Mizuho Asset Management sold 1,108 Vertex Pharmaceuticals shares in Q3 2016, an estimated $105K.
Vertex Pharmaceuticals made up 0.04% of Mizuho Asset Management's portfolio in Q3 2016, its #302 holding.
Mizuho Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
Mizuho Asset Management's Vertex Pharmaceuticals position peaked at $383K in Q4 2015.
490 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2016.

Based on Mizuho Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.